LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

48.60

+1.66 (3.54%)

At close: Oct 8, 2025, 4:00 PM EDT

47.65

-0.95 (-1.95%)

After-hours: Oct 8, 2025, 6:26 PM EDT

LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,386	794	-	-	-
Enterprise Value	1,178	578	-	-	-
Last Close Price	48.60	28.87	-	-	-
PB Ratio	6.71	3.89	-	-	-
P/TBV Ratio	6.72	3.89	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Asset Turnover	0.02	-	-	0.46	-
Quick Ratio	20.27	20.09	3.55	4.68	14.61
Current Ratio	20.54	20.36	3.63	4.91	14.62
Return on Equity (ROE)	-26.25%	-38.94%	-157.61%	-39.80%	-
Return on Assets (ROA)	-18.44%	-25.64%	-77.17%	-20.07%	-
Return on Capital (ROIC)	-19.26%	-28.47%	-101.31%	-24.01%	-
Earnings Yield	-3.78%	-6.27%	-	-	-
FCF Yield	-3.46%	-7.54%	-	-	-
Buyback Yield / Dilution	-222.30%	-986.27%	79.28%	-1.05%	-

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q